Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-02-06

Clinical Trial Update: A Study To Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of ASP2408 After Multiple Dose Subcutaneous Injections in Patients With Rheumatoid Arthritis on Methotrexate [Phase 1]

View source ↗

Summary

This Phase 1 study update assesses the pharmacokinetics, pharmacodynamics, safety and tolerability of ASP2408 after multiple subcutaneous doses in rheumatoid ar…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ASP2408

Snippet

Sponsor: Astellas Pharma Global Development, Inc. | Conditions: Rheumatoid Arthritis, Pharmacokinetics of ASP2408 | Phase 1 | Status: COMPLETED